Title
Management of Heart Failure
Authoring Organizations
Publication Month/Year
March 31, 2022
Last Updated Month/Year
November 26, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure” replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the “2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure.” The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure.
Target Patient Population
Patients with heart failure
PICO Questions
What are interventions that can prevent heart failure for patients with or at risk of developing cardiovascular disease (CVD) to improve quality of care and align with patients’ interests?
What measurements evaluate heart failure for patients with or at risk of developing cardiovascular disease (CVD) to improve quality of care and align with patients’ interests?
How is functional impairment and exercise intolerance measured in patients with or at risk of developing cardiovascular disease (CVD) to improve quality of care and align with patients’ interests?
What are potential barriers to effective self-care in patients with or at risk of developing cardiovascular disease (CVD)?
What medications are preferred for patients with or at risk of developing cardiovascular disease (CVD), and who have fluid retention?
What diuretics are used to treat congestion for patients with chronic heart failure?
What are potential barriers to effective self-care in patients with heart failure?
What devices and interventional therapies are recommended for patients with heart failure?
What are surgical options for patients with valvular heart disease versus utilizing medical therapy?
What inotropic agents prove most beneficial in prolonging life in patients with heart failure refractory to other therapies?
What subset of patients with advanced heart failure and reduced ejection fraction prove most successful with mechanical circulatory support?
What methods are used to prevent thromboembolism in the hospitalized patient with heart failure?
What approach to cardiogenic shock in patients with heart failure should be used by providers to prevent metabolic complications?
What types of disparities exist among social groups and heart failure diagnoses?
When is hospice and palliative care an option for a patient with advanced heart failure?
Inclusion Criteria
Male, Female, Adult, Older adult
Health Care Settings
Ambulatory, Emergency care, Hospital, Operating and recovery room
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Assessment and screening, Treatment, Prevention
Diseases/Conditions (MeSH)
D006333 - Heart Failure
Keywords
heart failure, heart failure with reduced ejection fraction (HFrEF), heart failure with preserved ejection fraction (HFpEF) , congestive heart failure (CHF)
Source Citation
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022; https://doi.org/10.1016/j.jacc.2021.12.012.
Copublished in Circulation. 2022; https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063.